Last Price | 44.09 | Max Price | 49.55 |
Min Price | 32.34 | 1 Year return | -13.95 |
Sector | Health Care | Subsector | Pharmaceuticals |
Annual report 2014 |
Contact info:Street: Orionintie 1APostbox: PO Box 65, FI-02101City: EspooCountry: FinlandPhone: 358-10-4261Website: www.orion.fiCEO: Timo LappalainenCFO: Jari Karlson
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 1,051 | 615,670 | 0.17 % |
2020 | 1,078 | 638,104 | 0.17 % |
2021 | 1,041 | 727,997 | 0.14 % |
2022 | 1,341 | 787,317 | 0.17 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the past year the company' stock gained around 38 percent. Orion' stock rose the past 5 years at around 197 percent. Orion's revenues between 2011 and 2015 were relatively stable and moved between 980,4 million euros and 1,02 billion euros. Orion's net results between 2011 and 2015 were very constant and moved between 209,5 million euros and 208,1 million euros.
Orion's headquarter is located in Espoo. The core activities of Orion are in the pharmaceutical sector. Timo Lappalainen is the company' CEO. The CFO of Orion the company is Jari Karlson. The global pharmaceutical companies gained around 75 percent over the last 10 years. Since 2011 the sector is 147 percent higher and over the past year minus 75 percent.
Orion paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 6,45 percent. Orion raised it's dividends per share each year in the past 5 years. So because of the yearly raised dividends per share Orion is a kind of dividend aristocrat.
At the end of 2015 Orion employed at around 1988 thousand people.
At the end of 2015 the Finnish company had a balance sheet of around 1,05 billion euros. The total debt of the pharmaceutical company was at the end of 2015 452,5 million euros, which equals around 43,2 percent of the total balance sheet. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 17. So the stock' value was 17 times the 2015' earnings per share. We could say that based on it's price/earnings-ratio and dividend yield the Finnish stock can be seen as a value stock.
The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 4,5 billion euros. At the end of 2015 the Finnish company had around 140,81 million stocks listed on the exchanges.
On this page you can find all Orion's financial reports. More information about Orion can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
1,016
|
1,074
|
1,085
|
978
|
1,051
|
1,078
|
Costs |
807
|
825
|
859
|
647
|
851
|
858
|
Profit |
208
|
249
|
226
|
330
|
200
|
220
|
Margin of profit |
20.50
|
23.20
|
20.84
|
33.79
|
19.07
|
20.40
|
ROI |
35.00
|
38.82
|
33.25
|
42.72
|
25.71
|
30.07
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
595
|
641
|
680
|
773
|
779
|
731
|
Debt |
453
|
422
|
376
|
374
|
256
|
384
|
Total assets |
1,047
|
1,063
|
1,056
|
1,147
|
1,036
|
1,116
|
Solvency |
56.80
|
60.34
|
64.40
|
67.42
|
75.25
|
65.55
|
Cash |
245
|
232
|
164
|
284
|
149
|
294
|
Cashflow |
255
|
249
|
228
|
231
|
271
|
299
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.56
|
0.59
|
0.61
|
0.62
|
1.06
|
0.78
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
31.97
|
42.29
|
31.08
|
30.28
|
41.27
|
Eps |
1.77
|
1.61
|
2.35
|
1.43
|
1.57
|
Price/earnings-ratio |
18.06
|
26.27
|
13.23
|
21.17
|
28.08
|
Dividend |
1.55
|
1.45
|
1.50
|
1.50
|
1.50
|
Dividend % |
4.85 %
|
3.43 %
|
4.83 %
|
4.95 %
|
3.40 %
|
Payout % |
0.88
|
0.90
|
0.64
|
1.05
|
0.96
|
Book value |
6.28
|
6.57
|
7.46
|
7.48
|
6.94
|
Market to book |
0.20
|
0.16
|
0.24
|
0.25
|
0.16
|
Cashflow per stock |
2.44
|
2.21
|
2.23
|
2.60
|
2.84
|
Stocks |
102
|
103
|
104
|
104
|
105
|
Market Cap |
3.266.70
|
4.375.41
|
3.219.11
|
3.153.87
|
4.644.44
|
Date
|
Price
|
---|---|
13 Nov 2024
|
44.09
|
08 Nov 2024
|
44.76
|
05 Nov 2024
|
45.10
|
31 Oct 2024
|
44.97
|
29 Oct 2024
|
44.60
|
23 Oct 2024
|
47.58
|
19 Oct 2024
|
47.63
|
16 Oct 2024
|
47.60
|
14 Oct 2024
|
47.97
|
05 Oct 2024
|
47.77
|
02 Oct 2024
|
49.02
|
27 Sep 2024
|
49.55
|
20 Sep 2024
|
47.14
|
17 Sep 2024
|
47.09
|
13 Sep 2024
|
47.10
|
28 Aug 2024
|
46.66
|
26 Aug 2024
|
46.60
|
23 Aug 2024
|
46.60
|
11 Aug 2024
|
44.11
|
07 Aug 2024
|
43.08
|
05 Aug 2024
|
41.61
|
01 Aug 2024
|
42.47
|
30 Jul 2024
|
41.54
|
26 Jul 2024
|
41.30
|
23 Jul 2024
|
39.81
|
16 Jul 2024
|
40.88
|
10 Jul 2024
|
40.79
|
09 Jul 2024
|
41.47
|
04 Jul 2024
|
41.51
|
02 Jul 2024
|
39.87
|